rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
22
|
pubmed:dateCreated |
2001-1-26
|
pubmed:abstractText |
The risk of Kaposi's sarcoma and non-Hodgkin's lymphoma is increased in people infected with the human immunodeficiency virus-1 (HIV). Highly active antiretroviral therapy (HAART) has been widely used by HIV-infected people in North America, Europe, and Australia since about 1997. Acquired immunodeficiency syndrome (AIDS) incidence and mortality rates have fallen markedly in association with the use of HAART, but its impact on the incidence of cancer in HIV-infected people is less clear.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0027-8874
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
92
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1823-30
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11078759-Adult,
pubmed-meshheading:11078759-Anti-HIV Agents,
pubmed-meshheading:11078759-Australia,
pubmed-meshheading:11078759-Europe,
pubmed-meshheading:11078759-Female,
pubmed-meshheading:11078759-Hodgkin Disease,
pubmed-meshheading:11078759-Humans,
pubmed-meshheading:11078759-Incidence,
pubmed-meshheading:11078759-International Cooperation,
pubmed-meshheading:11078759-Lymphoma, AIDS-Related,
pubmed-meshheading:11078759-Lymphoma, Non-Hodgkin,
pubmed-meshheading:11078759-Male,
pubmed-meshheading:11078759-Middle Aged,
pubmed-meshheading:11078759-Neoplasms,
pubmed-meshheading:11078759-North America,
pubmed-meshheading:11078759-Odds Ratio,
pubmed-meshheading:11078759-Sarcoma, Kaposi,
pubmed-meshheading:11078759-Uterine Cervical Neoplasms
|
pubmed:year |
2000
|
pubmed:articleTitle |
Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.
|
pubmed:affiliation |
Cancer Epidemiology Unit, Imperial Cancer Research Fund (ICRF), Oxford, UK.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|